Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-02-12 | Solace Therapeutics | Series E - II | $6.53M | |
2018-10-11 | Vapotherm | Series D - II | $10M | 3x5 Partners, Arnerich Massena & Associates, Gilde Healthcare Partners, Kaiser Permanente Ventures, Morgenthaler Ventures, QuestMark Partners, and Warburg Pincus |
2016-12-16 | Intrinsic Therapeutics | Series H | $28.43M | New Enterprise Associates, and New Leaf Venture Partners |
2016-09-06 | Solace Therapeutics | Series D | $13M | New Enterprise Associates |
2015-10-29 | Conventus Orthopaedics | Series A - III | $23.5M | Ally Bridge Group, BioStar Capital, Blue Sky Alternative Investments, Bluestem Capital Partners, Deerfield Management, and SightLine Partners |